SAN
JOSE, Calif., May
23, 2024 /PRNewswire/ -- Complete Genomics, a
pioneering genomic sequencing company, recently welcomed vendors,
suppliers, customers and employees to a May
17 grand opening celebration of its 10,115 square foot
manufacturing facility at its headquarters in San Jose, California. The facility represents
the company's inaugural U.S. supply chain, translating into faster
delivery times for the company's customers who are researchers
using next generation sequencing products to develop in-demand
diagnostics and therapies for conditions including cancer,
Alzheimer's, obesity, and others.
"Complete Genomics will integrate supply chain resources from
California, the United States, and globally to provide
more efficient and reliable local supply assurance for American
customers," said David Liu, VP of
Operation & Manufacturing at Complete Genomics.
The new facility houses Complete Genomics' research and
development, engineering and ISO (International Organization for
Standardization) manufacturing operations. The new facility will
enable faster delivery of instruments to U.S. customers with the
first DNBSEQ-G99* expected to be produced there in the
second quarter of this year. Complete Genomics expects to finish
and deliver dozens of DNBSEQ sequencers in 2024. A
2,766-square-foot reagent manufacturing facility is expected to
begin operating in 2025.
"As we all learned during the beginning of the Covid-19
pandemic, the global supply chain can be disrupted. This local
supply chain and manufacturing site will shorten the lead time and
provide better support and customer experience," said Dr. Radoje
(Rade) Drmanac, Co-Founder and Chief Scientific Officer of Complete
Genomics.
The grand opening event also featured the DNBSEQ-G800* and
DNBSEQ-E25* sequencers. Complete Genomics was established in
2005 in a 10,500 square foot facility in Sunnyvale, California. In 2008, the company
added a 66,000 square foot Mountain
View site. In May 2017,
Complete Genomics moved to its current 78,979 square foot location
in San Jose, which also includes a
warehousing facility.
Since the U.S. commercial launch of its DNBSEQ ™ sequencing
product line in August 2022, Complete
Genomics was recognized by the 2023 R&D 100 Awards in the
analytical testing category for its ultra-high throughput sequencer
aimed at making whole genome sequencing (WGS) affordable for every
lab. In 2023, the DNBSEQ T20X2RS* was named "Next Generation
Sequencing Solution of the Year" by the 2023 BioTech
Breakthrough Awards.
About Complete Genomics
Complete Genomics is a pioneering life sciences company that
provides novel, end to end DNA sequencing solutions. It has been at
the forefront of high throughput cost-effective sequencing
technology development since its inception in 2005. Our products
have powered over 7,600 publications across a wide array of
applications. To learn more,
visit www.completegenomics.com.
* For Research Use Only. Not for use in diagnostic
procedures.
Media Contact:
Betsy
Yates
Complete Genomics
byates@completegenomics.com
View original
content:https://www.prnewswire.com/news-releases/complete-genomics-opens-us-supply-chain-to-genomic-sequencing-customers-through-a-new-manufacturing-facility-at-its-san-jose-calif-headquarters-302150231.html
SOURCE Complete Genomics